$42.01 Nov 18, 2026 · market cap $3.8B
Crispr Therapeutics trades at $42. We don't have a valuation for it yet.
NEUTRAL · low confidence · Sep 23, 2026
7 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app